Silgan Holdings stock kpis
Want to see SLGN full AI Analyst Report?
Net Sales by Segment
Silgan Holdings reported net sales by segment of $2.04B in Q3 2026, up 24.2% from Q2 2026 and up 1.6% year over year. This is the highest value since 2021.
Breaks down sales across Silgan’s product and business segments to show which parts of the company drive top-line growth. The mix highlights concentration risks, whether higher-value products are gaining share, and how price or volume trends in specific segments could affect overall revenue momentum.
Metal Containers’ topline shows marked seasonality and recent re-acceleration—largely driven by contractual pass-through and mid-single-digit pet-food volume gains—so revenue growth may overstate margin strength (management flagged mix pressure, human-food weakness and a ~$10M resin headwind). Dispensing & Specialty Closures is a steadier, higher-value growth engine (fragrance and healthcare upside and low‑to‑mid single‑digit organic volume gains). Customer Containers posts stable sales but improving profitability from pricing and footprint optimization, meaning margins and cash flow could meaningfully improve as H2 commercialization restores volumes; guidance/FCF targets remain supportive.
SLGN Net Sales by Segment
| Period | Dispensing & Speciality Closures | Metal Containers | Customer Containers | Total |
|---|---|---|---|---|
| Q3 2026Sep 30, 2026 | $699.20M | $1.17B | $166.80M | $2.04B |
| Q2 2026Jun 30, 2026 | $713.90M | $763.90M | $165.50M | $1.64B |
| Q1 2026Mar 31, 2026 | $685.32M | $724.87M | $151.07M | $1.56B |
| Q4 2025Dec 31, 2025 | $643.57M | $675.61M | $149.43M | $1.47B |
| Q3 2025Sep 30, 2025 | $690.38M | $1.16B | $160.13M | $2.01B |
| Q2 2025Jun 30, 2025 | $702.19M | $676.06M | $160.92M | $1.54B |
| Q1 2025Mar 31, 2025 | $671.10M | $628.43M | $167.13M | $1.47B |
| Q4 2024Dec 31, 2024 | $639.40M | $610.15M | $161.62M | $1.41B |
| Q3 2024Sep 30, 2024 | $563.67M | $1.02B | $158.85M | $1.75B |
| Q2 2024Jun 30, 2024 | $565.38M | $650.80M | $165.19M | $1.38B |
| Q1 2024Mar 31, 2024 | $535.92M | $617.13M | $163.99M | $1.32B |
| Q4 2023Dec 31, 2023 | $522.32M | $665.26M | $152.51M | $1.34B |
| Q3 2023Sep 30, 2023 | $559.08M | $1.09B | $149.41M | $1.80B |
| Q2 2023Jun 30, 2023 | $560.10M | $710.86M | $155.77M | $1.43B |
| Q1 2023Mar 31, 2023 | $579.93M | $670.10M | $168.25M | $1.42B |
| Q4 2022Dec 31, 2022 | $540.80M | $754.62M | $159.97M | $1.46B |
| Q3 2022Sep 30, 2022 | $575.53M | $1.21B | $182.88M | $1.97B |
| Q2 2022Jun 30, 2022 | $602.43M | $754.40M | $186.95M | $1.54B |
| Q1 2022Mar 31, 2022 | $597.93M | $650.73M | $193.23M | $1.44B |
| Q4 2021Dec 31, 2021 | $572.03M | $687.33M | $180.00M | $1.44B |
| Q3 2021Sep 30, 2021 | $533.33M | $942.13M | $175.62M | $1.65B |
| Q2 2021Jun 30, 2021 | $545.77M | $624.53M | $178.36M | $1.35B |
| Q1 2021Mar 31, 2021 | $509.35M | $554.08M | $174.68M | $1.24B |

